FDA Warning Letter — Hangzhou Karic Commodities Co., Ltd.

Case 556676 — FEI 3006528506

The FDA took a Warning Letter action against Hangzhou Karic Commodities Co., Ltd. on July 31, 2018 (Hangzhou, China). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.

Action Details

Facility
Hangzhou Karic Commodities Co., Ltd.
Date
July 31, 2018
Fiscal Year
2018
Product Type
Drugs
Center
CDER
Location
Hangzhou (China)